Kangstem Biotech Decides on 48 Billion KRW Rights Offering
Kangstem Biotech, a KOSDAQ-listed company, announced on the 10th that it has decided to raise approximately 48 billion KRW through a rights offering followed by a public offering of forfeited shares, in order to secure operating funds and for other purposes.
Hot Picks Today
!["What Should I Eat? Cooking at Home Is a Hassle... 10,000~20,000 Won 'Hotel-Level Catering' Spreads in Ultra-Luxury Apartments [Luxury World]"](https://cwcontent.asiae.co.kr/asiaresize/93/2026042610544940447_1777168490.png)
"What Should I Eat? Cooking at Home Is a Hassle...
- Even with KOSPI at 6,500..."Selling Samsung and SK hynix for Cash," Individuals ...
- "Up to 600,000 Won Per Person, Finally Available"... Be Careful: Filling Up at Y...
- "Survived Thanks to Korean Choco Pie"...How a Vietnamese University Student Endu...
- No Work, No Inheritance for the Eldest... 30 Billion KRW in Shares Gifted to Sec...
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
